Zymeworks Inc. (ZYME) Cash Flow Statement
Zymeworks Inc. (ZYME) generated -$119.3M of operating cash flow over the twelve months to 2026-06-30, spent $1.2M on capital expenditure and had free cash flow of -$120.5M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ZYMEZymeworks Inc.Follow ZYME — free
—
Price chart with a free account
- Market cap
- 2.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|
| Operating cash flow | 144.1 | -118.3 | -110.1 | -33.0 | -119.3 | |
| Capital expenditure | 8.2 | 2.5 | 2.0 | 1.5 | -1.2 | |
| Free cash flow | 136.0 | -120.8 | -112.0 | -34.5 | -120.5 | |
| Share repurchases | — | 0.0 | 30.1 | 41.7 | — | |
| Stock-based compensation | 4.0 | 8.1 | 17.8 | 28.0 | — |
USD millions · SEC XBRL
Zymeworks Inc. — questions
- What is Zymeworks Inc.'s operating cash flow?
- -$119.3M over the twelve months to 2026-06-30.
- How much does Zymeworks Inc. spend on capital expenditure?
- $1.2M over the twelve months to 2026-06-30.
- What is Zymeworks Inc.'s free cash flow?
- -$120.5M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from Zymeworks Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.